Immuron Ltd
IMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660046
No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Immuron Ltd changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 1 | 3 | +2 |
| Shares | 5.94K | 6.10K | +160 (+2.7%) |
| Value | $10.5K | $10.8K | +$347 (+3.3%) |
New holders (2)
Institutions that held Immuron Ltd at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wells Fargo & Company | 150 | $270 | 0.00% |
| SBI Securities Co., Ltd. | 10 | $18 | 0.00% |
Sold out (0)
Institutions that held Immuron Ltd at the end of Q4 2024 and filed for Q1 2025 without it.
None.